Galileo Pharmaceuticals, Inc

Galileo Pharmaceuticals, Inc. is focused on the discovery and development of small molecule therapeutics to treat metabolic diseases and other disorders mediated by inflammation. We are a privately-held, venture-backed company headquartered in Santa Clara, California. Our major investors include Alloy Ventures, Bay City Capital, Bio*One Capital, Inventages Venture Capital, and the Johnson & Johnson Development Corporation

Contact Details: 5301 Patrick Henry Drive Santa Clara California 95054 United States of America Tel: 408.654.5830 Fax: 408.654.5831 Email: rd@galileopharma.com WWW: www.galileolabs.com/

Loading...

Galileo Pharmaceuticals, Inc Patents:
US Patent No.	Title
7119117	Tocopherol enriched compositions and amelioration of inflammatory symptoms
7081476	Tocopherol enriched compositions for reducing IL6 levels
7078541	Benzofuran derivatives
7034054	Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols
6916850	Pyruvate derivatives
→View more Galileo Pharmaceuticals, Inc patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 456 times since April 2007, the link to the organisation's website has been followed 83 times

Recent Search Terms used to find this page: galileo bayer | 2007 Galileo Pharmaceuticals Inc | .

Search for more companies in Santa Clara

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Galileo Pharmaceuticals, Inc